Showing results (1231-1240 of 1,293) with videos related to

Sort By:
Pageof 130
Rheumatology (Oxford, England)|March 24, 2022
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritisMichael Nissen, Bénédicte Delcoigne, Daniela Di Giuseppe, et al.
BMJ Neurology Open|August 29, 2025
Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccinationAnne Hege Aamodt, Thor Ueland, Marion Boldingh, et al.
EULAR Rheumatology Open|June 29, 2026
The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patientsZohra Faizy Ahmadzay, Stylianos Georgiadis, Mikkel Østergaard, et al.
Frontiers in Immunology|September 26, 2022
Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunityArne Søraas, Gunnveig Grødeland, Beathe Kiland Granerud, et al.
Rheumatology (Oxford, England)|June 14, 2023
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registriesLouise Linde, Lykke M Ørnbjerg, Stylianos Georgiadis, et al.
The Journal of Rheumatology|February 1, 2025
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration NetworkMarion Pons, Stylianos Georgiadis, Merete Lund Hetland, et al.
RMD Open|September 20, 2020
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaborationBrigitte Michelsen, Ulf Lindström, Catalin Codreanu, et al.
Seminars in Arthritis and Rheumatism|August 19, 2022
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaborationLykke M Ørnbjerg, Louise Linde, Stylianos Georgiadis, et al.
Journal of Medicinal Chemistry|November 10, 2015
Discovery and Structure-Guided Optimization of Diarylmethanesulfonamide Disrupters of Glucokinase-Glucokinase Regulatory Protein (GK-GKRP) Binding: Strategic Use of a N → S (nN → σ*S-X) Interaction for Conformational ConstraintLewis D Pennington, Michael D Bartberger, Michael D Croghan, et al.
EULAR Rheumatology Open|June 29, 2026
Differential joint-level response to secukinumab in psoriatic arthritis: A collaborative European observational cohort studyAnnik Steimer, Andrea Götschi, Jonas Brändli, et al.
Pageof 130